Evidence map›Paper›PMID 31794427›Full record

ArticleAging2019

Ninjurin2 overexpression promotes glioma cell growth.

Li-Na Zhou, Ping Li, Shang Cai, Gang Li, Fang Liu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Four-Octyl Itaconate Protects Chondrocytes against HOxidative medicine and cellular longevity · 2022
    Article
  11. Luteolin Protects Chondrocytes from HOxidative medicine and cellular longevity · 2022
    Article
  12. The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth.International journal of biological sciences · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Li-Na ZhouDepartment of Radiotherapy and Oncology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, China.
Ping LiDepartment of Radiotherapy and Oncology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, China.
Shang CaiDepartment of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Gang LiDepartment of Chemoradiation Oncology, The First affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Fang LiuDepartment of Neurosurgery, Nanjing Medical University Affiliated Changzhou No. 2 People's Hospital, Changzhou, Jiangsu, China.
First Affiliated Hospital of Wenzhou Medical University · CNFirst People's Hospital of Kunshan · CNJiangsu University · CNNanjing Medical University · CNSecond Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ninjurin2 (Ninj2) is an adhesion protein expressed in neurons and glial cells. The current study tested its expression and potential functions in human glioma. We show that

Indexed as

Brain NeoplasmsCell Adhesion Molecules, NeuronalCell ProliferationGliomaHumansCell Adhesion Molecules, NeuronalNINJ2 protein, humanAktgliomaNinj2receptor tyrosine kinases

Identifiers

PMID31794427
PMCPMC6932907
OpenAlexW2991757083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.